论文信息 - Cyclin-Dependent Kinase 4/6 Inhibitors as Neoadjuvant Therapy of Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: What do we Know so Far? - 字舞流文

Cyclin-Dependent Kinase 4/6 Inhibitors as Neoadjuvant Therapy of Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: What do we Know so Far?

E. Kotteas | Konstantinos Drougkas | Konstantinos Karampinos | Ioannis Karavolias | Ioanna Ploumaki | Efthymios Triantafyllou | Ioannis-Alexios Koumprentziotis | Ioannis‐Alexios Koumprentziotis